BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25931004)

  • 1. Genistein increases estrogen receptor beta expression in prostate cancer via reducing its promoter methylation.
    Mahmoud AM; Al-Alem U; Ali MM; Bosland MC
    J Steroid Biochem Mol Biol; 2015 Aug; 152():62-75. PubMed ID: 25931004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of soy phytoestrogens and 17β-estradiol on DNA methylation of a panel of 24 genes in prostate cancer cell lines.
    Adjakly M; Ngollo M; Lebert A; Dagdemir A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
    Nutr Cancer; 2014; 66(3):474-82. PubMed ID: 24641702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines.
    Adjakly M; Bosviel R; Rabiau N; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
    Epigenomics; 2011 Dec; 3(6):795-803. PubMed ID: 22126297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis.
    Zhu X; Leav I; Leung YK; Wu M; Liu Q; Gao Y; McNeal JE; Ho SM
    Am J Pathol; 2004 Jun; 164(6):2003-12. PubMed ID: 15161636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the estrogen receptor beta in genistein-induced expression of p21(waf1/cip1) in PC-3 prostate cancer cells.
    Matsumura K; Tanaka T; Kawashima H; Nakatani T
    Anticancer Res; 2008; 28(2A):709-14. PubMed ID: 18507011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene.
    Cao F; Jin TY; Zhou YF
    Biomed Environ Sci; 2006 Feb; 19(1):35-41. PubMed ID: 16673816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells.
    Zhang X; Leung YK; Ho SM
    Oncogene; 2007 Nov; 26(52):7346-54. PubMed ID: 17525739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfiram and its novel derivative sensitize prostate cancer cells to the growth regulatory mechanisms of the cell by re-expressing the epigenetically repressed tumor suppressor-estrogen receptor β.
    Sharma V; Verma V; Lal N; Yadav SK; Sarkar S; Mandalapu D; Porwal K; Rawat T; Maikhuri JP; Rajender S; Sharma VL; Gupta G
    Mol Carcinog; 2016 Nov; 55(11):1843-1857. PubMed ID: 26599461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCAAT enhancer binding protein β promotes tumor growth and inhibits apoptosis in prostate cancer by methylating estrogen receptor β.
    Li D; Liu J; Huang S; Bi X; Wang B; Chen Q; Chen H; Pu X
    Neoplasma; 2018; 65(1):34-41. PubMed ID: 29322786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and clinical implication of combined chemotherapy with cisplatin and oestrogen in prostate cancer: primary evidence based on methylation analysis of oestrogen receptor-alpha.
    Moriyama-Gonda N; Shiina H; Terashima M; Satoh K; Igawa M
    BJU Int; 2008 Feb; 101(4):485-91. PubMed ID: 17922863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions.
    Rody A; Holtrich U; Solbach C; Kourtis K; von Minckwitz G; Engels K; Kissler S; Gätje R; Karn T; Kaufmann M
    Endocr Relat Cancer; 2005 Dec; 12(4):903-16. PubMed ID: 16322330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells.
    Piccolella M; Crippa V; Messi E; Tetel MJ; Poletti A
    Pharmacol Res; 2014 Jan; 79():13-20. PubMed ID: 24184124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the germline methylation status in ERβ promoter and the risk in prostate cancer: a prospective study.
    Wang L; Zhang P; Meng X; Chen X; Xiang Z; Lin X; Liu Y; Gan W; Han X; Li D
    Fam Cancer; 2016 Apr; 15(2):309-15. PubMed ID: 26547439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer.
    Majid S; Dar AA; Shahryari V; Hirata H; Ahmad A; Saini S; Tanaka Y; Dahiya AV; Dahiya R
    Cancer; 2010 Jan; 116(1):66-76. PubMed ID: 19885928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines.
    Walton TJ; Li G; Seth R; McArdle SE; Bishop MC; Rees RC
    Prostate; 2008 Feb; 68(2):210-22. PubMed ID: 18092350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S; Kyo S; Banerjee PP
    Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: correlation with Gleason score.
    Liu W; Gong J; Hu J; Hu T; Sun Y; Du J; Sun C; Guan M; Jiang H; Lu Y
    Urology; 2011 Apr; 77(4):1006.e1-7. PubMed ID: 21310466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies on the modification of low-dose hyper-radiosensitivity in prostate cancer cells by incubation with genistein and estradiol.
    Hermann RM; Wolff HA; Jarry H; Thelen P; Gruendker C; Rave-Fraenk M; Schmidberger H; Christiansen H
    Radiat Oncol; 2008 Jul; 3():19. PubMed ID: 18625043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.